OYSTER SHELL

OYSTER SHELL was reported 535 times

OYSTER SHELL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EAR, NOSE AND THROAT INFECTION 1 0.0122
1 INCISION SITE CELLULITIS 1 0.0093
2 HYPOPHOSPHATASIA 1 0.0088
3 RECTAL LESION 1 0.0064
4 MONONEURITIS 1 0.0064
5 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY INCREASED 1 0.0060
6 EYELID INJURY 1 0.0057
7 IRREGULAR SLEEP WAKE RHYTHM DISORDER 1 0.0050
8 EAR INFECTION BACTERIAL 1 0.0037
9 LABILE HYPERTENSION 1 0.0036
10 STEROID THERAPY 1 0.0035
11 AVULSION FRACTURE 1 0.0035
12 SEPTIC ARTHRITIS STAPHYLOCOCCAL 1 0.0029
13 MENTAL RETARDATION 1 0.0028
14 CERVICAL POLYP 1 0.0026
15 ROOT CANAL INFECTION 1 0.0020
16 ORAL LICHEN PLANUS 1 0.0020
17 INFUSION SITE DISCOMFORT 2 0.0019
18 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
19 ALLERGY TO METALS 1 0.0016
20 INHALATION THERAPY 1 0.0016
21 BLOOD OESTROGEN DECREASED 1 0.0014
22 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
23 BRONCHIAL CARCINOMA 1 0.0013
24 THYROID HORMONES DECREASED 1 0.0013
25 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
26 SEPTIC EMBOLUS 1 0.0012
27 MYOCARDIAL FIBROSIS 1 0.0012
28 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
29 LIGAMENT DISORDER 1 0.0011
30 RED BLOOD CELL ABNORMALITY 1 0.0010
31 GASTRIC PH DECREASED 1 0.0010
32 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
33 CARDIAC HYPERTROPHY 1 0.0009
34 SEROMA 1 0.0008
35 INFUSION SITE RASH 1 0.0007
36 TRICHORRHEXIS 2 0.0007
37 RESPIRATORY SYMPTOM 2 0.0007
38 FAT TISSUE INCREASED 1 0.0007
39 INFUSION SITE INDURATION 1 0.0007
40 OSTEOMALACIA 1 0.0006
41 BRONCHIAL DISORDER 1 0.0006
42 INFUSION SITE PRURITUS 2 0.0006
43 SHOULDER FRACTURE 1 0.0006
44 DENTAL IMPLANTATION 1 0.0006
45 VEIN RUPTURE 1 0.0006
46 RECALLED PRODUCT 1 0.0006
47 JOINT ARTHROPLASTY 1 0.0006
48 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
49 PLASMACYTOMA 1 0.0005
50 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
51 BLOOD IRON INCREASED 1 0.0005
52 JOINT CREPITATION 1 0.0005
53 MICROCYTIC ANAEMIA 1 0.0005
54 EYE CONTUSION 1 0.0005
55 SLEEP DEFICIT 1 0.0005
56 INFUSION SITE BRUISING 1 0.0005
57 SPUTUM INCREASED 1 0.0005
58 CERVICAL DYSPLASIA 1 0.0005
59 DIABETIC NEPHROPATHY 1 0.0005
60 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
61 WHEELCHAIR USER 2 0.0004
62 TEMPERATURE REGULATION DISORDER 1 0.0004
63 NEPHROGENIC ANAEMIA 2 0.0004
64 EOSINOPHIL COUNT DECREASED 1 0.0004
65 RETROPERITONEAL HAEMORRHAGE 1 0.0004
66 DEVICE INFUSION ISSUE 1 0.0004
67 ABDOMINAL INFECTION 1 0.0004
68 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
69 RADICULOPATHY 1 0.0004
70 GASTROINTESTINAL INJURY 1 0.0004
71 CHONDROPATHY 1 0.0004
72 FIBULA FRACTURE 1 0.0003
73 INFUSION SITE REACTION 1 0.0003
74 REBOUND ACID HYPERSECRETION 1 0.0003
75 THROMBOSIS IN DEVICE 1 0.0003
76 INFUSION SITE HAEMORRHAGE 1 0.0003
77 NEAR DEATH EXPERIENCE 1 0.0003
78 CHRONIC SINUSITIS 1 0.0003
79 SENSATION OF HEAVINESS 1 0.0003
80 ORAL INFECTION 1 0.0003
81 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
82 MYASTHENIA GRAVIS 2 0.0002
83 POST PROCEDURAL INFECTION 2 0.0002
84 SOCIAL PROBLEM 1 0.0002
85 AORTIC VALVE INCOMPETENCE 1 0.0002
86 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
87 PRODUCT DISPENSING ISSUE 1 0.0002
88 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
89 GINGIVAL SWELLING 1 0.0002
90 BLOOD CREATINE INCREASED 1 0.0002
91 CATHETERISATION CARDIAC 1 0.0002
92 PRODUCT DISTRIBUTION ISSUE 2 0.0002
93 RENAL FUNCTION TEST ABNORMAL 1 0.0002
94 TIBIA FRACTURE 1 0.0002
95 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
96 DIABETIC NEUROPATHY 1 0.0002
97 PROTEIN URINE PRESENT 1 0.0002
98 WEIGHT LOSS POOR 1 0.0002
99 POLYARTHRITIS 1 0.0002
100 COMPRESSION FRACTURE 1 0.0002
101 GINGIVITIS 1 0.0002
102 CYSTIC FIBROSIS 1 0.0002
103 STREPTOCOCCAL INFECTION 1 0.0002
104 EXERCISE TOLERANCE DECREASED 1 0.0002
105 MENISCUS INJURY 1 0.0002
106 SCOLIOSIS 1 0.0002
107 INFUSION SITE PAIN 2 0.0002
108 EAR INFECTION 4 0.0002
109 FULL BLOOD COUNT DECREASED 3 0.0001
110 ULCER HAEMORRHAGE 1 0.0001
111 ONYCHOCLASIS 1 0.0001
112 HYPERTRANSAMINASAEMIA 1 0.0001
113 FEAR OF INJECTION 1 0.0001
114 SKIN CANCER 3 0.0001
115 INSURANCE ISSUE 2 0.0001
116 ANKLE FRACTURE 2 0.0001
117 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
118 PULMONARY HAEMORRHAGE 1 0.0001
119 AFFECTIVE DISORDER 1 0.0001
120 TRICUSPID VALVE INCOMPETENCE 1 0.0001
121 ABNORMAL FAECES 1 0.0001
122 MULTIPLE FRACTURES 2 0.0001
123 HYPERAESTHESIA 1 0.0001
124 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
125 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
126 MUSCULOSKELETAL DISCOMFORT 2 0.0001
127 MUSCLE STRAIN 1 0.0001
128 SKIN SWELLING 1 0.0001
129 NAIL DISORDER 1 0.0001
130 MYOSITIS 1 0.0001
131 NERVE COMPRESSION 1 0.0001
132 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
133 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
134 HYPOCALCAEMIA 2 0.0001
135 ATELECTASIS 1 0.0001
136 DIZZINESS POSTURAL 1 0.0001
137 VITAMIN D DEFICIENCY 1 0.0001
138 HOSPICE CARE 1 0.0001
139 EYELID PTOSIS 1 0.0001
140 DRY THROAT 1 0.0001
141 TENDERNESS 1 0.0001
142 TRANSFUSION 1 0.0001
143 JOINT DISLOCATION 1 0.0001
144 OSTEOARTHRITIS 4 0.0001
145 HEREDITARY ANGIOEDEMA 1 0.0001
146 WOUND INFECTION 1 0.0001
147 ASPIRATION 1 0.0001
148 VIRAL INFECTION 3 0.0001
149 VENTRICULAR FIBRILLATION 1 0.0001
150 TYPE 2 DIABETES MELLITUS 3 0.0001
151 EYE INFECTION 1 0.0001
152 IMPAIRED DRIVING ABILITY 1 0.0001
153 DERMATITIS CONTACT 1 0.0001
154 VASCULITIS 1 0.0001
155 ACCIDENT 1 0.0001
156 BURSITIS 1 0.0001
157 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
158 SECRETION DISCHARGE 1 0.0001
159 DERMATITIS ALLERGIC 1 0.0001
160 CHRONIC KIDNEY DISEASE 6 0.0001
161 ROTATOR CUFF SYNDROME 1 0.0001
162 ILLNESS 8 0.0001
163 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
164 ORAL CANDIDIASIS 1 0.0001
165 TOOTH INFECTION 1 0.0001
166 LIMB INJURY 2 0.0001
167 FEELING COLD 2 0.0001
168 APHONIA 1 0.0001
169 CARPAL TUNNEL SYNDROME 1 0.0001
170 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
171 SEASONAL ALLERGY 1 0.0001
172 IMPAIRED QUALITY OF LIFE 1 0.0001
173 ANOSMIA 1 0.0001
174 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
175 PULMONARY MASS 1 0.0001
176 HYPOAESTHESIA ORAL 1 0.0001
177 OSTEOPENIA 1 0.0001
178 DEVICE RELATED INFECTION 1 0.0001
179 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
180 THYROID DISORDER 1 0.0001
181 SCIATICA 1 0.0001
182 MUSCLE TIGHTNESS 1 0.0001
183 MUSCULAR WEAKNESS 7 0.0001
184 BLOOD POTASSIUM INCREASED 1 0.0001
185 BACK DISORDER 1 0.0001
186 STAPHYLOCOCCAL INFECTION 2 0.0001
187 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
188 PERICARDITIS 1 0.0001
189 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
190 LOCAL SWELLING 1 0.0001
191 HYPERKALAEMIA 2 0.0001
192 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
193 LYMPHOCYTE COUNT DECREASED 1 0.0001
194 HEAD DISCOMFORT 1 0.0001
195 PLATELET COUNT DECREASED 6 0.0001
196 LEUKOCYTOSIS 1 0.0001
197 OSTEOMYELITIS 1 0.0001
198 BONE DISORDER 1 0.0001
199 END STAGE RENAL DISEASE 1 0.0001
200 BACTERIAL INFECTION 1 0.0001
201 FOOT FRACTURE 1 0.0001
202 SLEEP APNOEA SYNDROME 1 0.0001
203 POST PROCEDURAL COMPLICATION 1 0.0001
204 LOWER LIMB FRACTURE 1 0.0001
205 GLAUCOMA 1 0.0001
206 DYSPHONIA 3 0.0001
207 HAEMORRHOIDS 1 0.0001
208 PLASMA CELL MYELOMA 2 0.0001
209 BONE PAIN 3 0.0001
210 SKIN FISSURES 1 0.0001
211 SPINAL FRACTURE 1 0.0000
212 PRODUCT ADMINISTRATION ERROR 1 0.0000
213 STOMATITIS 3 0.0000
214 FEEDING DISORDER 1 0.0000
215 TASTE DISORDER 1 0.0000
216 PRODUCT PREPARATION ERROR 1 0.0000
217 OSTEOPOROSIS 2 0.0000
218 TOOTH LOSS 1 0.0000
219 ROAD TRAFFIC ACCIDENT 2 0.0000
220 KNEE ARTHROPLASTY 1 0.0000
221 JOINT INJURY 1 0.0000
222 POOR QUALITY SLEEP 1 0.0000
223 INFUSION RELATED REACTION 3 0.0000
224 ORAL PAIN 1 0.0000
225 SNEEZING 1 0.0000
226 NEPHROLITHIASIS 2 0.0000
227 INJECTION SITE REACTION 3 0.0000
228 PERICARDIAL EFFUSION 1 0.0000
229 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
230 SLEEP DISORDER 3 0.0000
231 NEUROPATHY PERIPHERAL 4 0.0000
232 THERAPY INTERRUPTED 3 0.0000
233 MIGRAINE 4 0.0000
234 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
235 LOCALISED INFECTION 1 0.0000
236 MENTAL IMPAIRMENT 1 0.0000
237 FIBROMYALGIA 1 0.0000
238 LUNG DISORDER 2 0.0000
239 PRODUCT DOSE OMISSION ISSUE 12 0.0000
240 INJECTION SITE URTICARIA 1 0.0000
241 BRONCHITIS 3 0.0000
242 ABASIA 1 0.0000
243 PNEUMONIA ASPIRATION 1 0.0000
244 ABDOMINAL PAIN LOWER 1 0.0000
245 HAEMATEMESIS 1 0.0000
246 SINUSITIS 4 0.0000
247 HAEMATOMA 1 0.0000
248 RESPIRATORY TRACT INFECTION 1 0.0000
249 SPEECH DISORDER 2 0.0000
250 ANHEDONIA 1 0.0000
251 INJECTION SITE BRUISING 3 0.0000
252 MENSTRUATION IRREGULAR 1 0.0000
253 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
254 FREQUENT BOWEL MOVEMENTS 1 0.0000
255 MOOD ALTERED 1 0.0000
256 ABNORMAL DREAMS 1 0.0000
257 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
258 DEMENTIA 1 0.0000
259 WOUND 1 0.0000
260 URINARY TRACT INFECTION 6 0.0000
261 INTENTIONAL DOSE OMISSION 1 0.0000
262 HERPES ZOSTER 2 0.0000
263 LETHARGY 2 0.0000
264 NEEDLE ISSUE 1 0.0000
265 MUSCULOSKELETAL STIFFNESS 3 0.0000
266 PNEUMONIA 11 0.0000
267 LABORATORY TEST ABNORMAL 1 0.0000
268 RENAL INJURY 1 0.0000
269 HYPOAESTHESIA 5 0.0000
270 LACRIMATION INCREASED 1 0.0000
271 ILL-DEFINED DISORDER 2 0.0000
272 BLOOD PRESSURE INCREASED 5 0.0000
273 INJECTION SITE RASH 1 0.0000
274 LIMB DISCOMFORT 1 0.0000
275 INJECTION SITE ERYTHEMA 4 0.0000
276 GAIT DISTURBANCE 6 0.0000
277 HYPOTHYROIDISM 1 0.0000
278 HIP FRACTURE 1 0.0000
279 CHOLELITHIASIS 1 0.0000
280 EXPIRED PRODUCT ADMINISTERED 1 0.0000
281 FALL 10 0.0000
282 FUNGAL INFECTION 1 0.0000
283 INJECTION SITE PRURITUS 2 0.0000
284 HAEMATURIA 1 0.0000
285 NIGHTMARE 1 0.0000
286 COVID-19 5 0.0000
287 FATIGUE 22 0.0000
288 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
289 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
290 RASH 12 0.0000
291 CRYING 1 0.0000
292 CONSTIPATION 6 0.0000
293 MUSCLE SPASMS 5 0.0000
294 NASOPHARYNGITIS 5 0.0000
295 DYSGEUSIA 2 0.0000
296 EYE SWELLING 1 0.0000
297 ASTHMA 3 0.0000
298 UNEVALUABLE EVENT 2 0.0000
299 COLITIS 1 0.0000
300 DIABETES MELLITUS 2 0.0000
301 INJECTION SITE SWELLING 2 0.0000
302 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
303 HOSPITALISATION 4 0.0000
304 PRURITUS 10 0.0000
305 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
306 ALOPECIA 5 0.0000
307 DISORIENTATION 1 0.0000
308 WEIGHT DECREASED 7 0.0000
309 COUGH 7 0.0000
310 THROMBOSIS 2 0.0000
311 BLINDNESS 1 0.0000
312 NEUTROPHIL COUNT DECREASED 1 0.0000
313 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
314 POLLAKIURIA 1 0.0000
315 ASTHENIA 9 0.0000
316 CARDIO-RESPIRATORY ARREST 1 0.0000
317 WITHDRAWAL SYNDROME 1 0.0000
318 HYPERTENSION 5 0.0000
319 DIARRHOEA 15 0.0000
320 CONDITION AGGRAVATED 7 0.0000
321 SEPTIC SHOCK 1 0.0000
322 INTENTIONAL PRODUCT MISUSE 2 0.0000
323 RENAL FAILURE 3 0.0000
324 PULMONARY OEDEMA 1 0.0000
325 THERAPY NON-RESPONDER 1 0.0000
326 HYPOKALAEMIA 1 0.0000
327 BLOOD CHOLESTEROL INCREASED 1 0.0000
328 SWELLING 2 0.0000
329 ARRHYTHMIA 1 0.0000
330 DYSPHAGIA 2 0.0000
331 ANAEMIA 4 0.0000
332 BLOOD GLUCOSE DECREASED 1 0.0000
333 CONTUSION 2 0.0000
334 MALAISE 9 0.0000
335 HEART RATE INCREASED 2 0.0000
336 SOMNOLENCE 4 0.0000
337 CELLULITIS 1 0.0000
338 FLUID RETENTION 1 0.0000
339 PAIN 12 0.0000
340 THERAPY CESSATION 1 0.0000
341 INFLAMMATION 1 0.0000
342 ARTHRALGIA 8 0.0000
343 ABDOMINAL DISTENSION 2 0.0000
344 NERVOUSNESS 1 0.0000
345 PANCREATITIS 1 0.0000
346 DEPRESSED MOOD 1 0.0000
347 OEDEMA 1 0.0000
348 TREATMENT NONCOMPLIANCE 1 0.0000
349 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
350 DRUG DOSE OMISSION 3 0.0000
351 HAEMATOCHEZIA 1 0.0000
352 ANAPHYLACTIC REACTION 1 0.0000
353 INFLUENZA 2 0.0000
354 SEPSIS 2 0.0000
355 URTICARIA 3 0.0000
356 NECK PAIN 1 0.0000
357 OXYGEN SATURATION DECREASED 1 0.0000
358 FLATULENCE 1 0.0000
359 INCORRECT DOSE ADMINISTERED 4 0.0000
360 BACK PAIN 4 0.0000
361 MYOCARDIAL INFARCTION 3 0.0000
362 NASAL CONGESTION 1 0.0000
363 DISEASE PROGRESSION 2 0.0000
364 WHEEZING 1 0.0000
365 CATARACT 1 0.0000
366 FEELING ABNORMAL 4 0.0000
367 NAUSEA 13 0.0000
368 FEELING HOT 1 0.0000
369 INJECTION SITE PAIN 5 0.0000
370 RHINORRHOEA 1 0.0000
371 AMNESIA 1 0.0000
372 PRODUCT DOSE OMISSION 1 0.0000
373 BLOOD CREATININE INCREASED 1 0.0000
374 FEBRILE NEUTROPENIA 1 0.0000
375 BLOOD PRESSURE DECREASED 1 0.0000
376 DEHYDRATION 2 0.0000
377 ERYTHEMA 3 0.0000
378 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
379 VISION BLURRED 2 0.0000
380 MEMORY IMPAIRMENT 2 0.0000
381 DEVICE MALFUNCTION 1 0.0000
382 INFECTION 2 0.0000
383 AGITATION 1 0.0000
384 PAIN IN EXTREMITY 4 0.0000
385 WEIGHT INCREASED 3 0.0000
386 EPISTAXIS 1 0.0000
387 HALLUCINATION 1 0.0000
388 HOT FLUSH 1 0.0000
389 DEPRESSION 3 0.0000
390 ACUTE KIDNEY INJURY 2 0.0000
391 DECREASED APPETITE 3 0.0000
392 DEATH 11 0.0000
393 HEADACHE 8 0.0000
394 ARTHRITIS 1 0.0000
395 OFF LABEL USE 11 0.0000
396 INJECTION SITE HAEMORRHAGE 1 0.0000
397 PROSTATE CANCER 1 0.0000
398 DRY MOUTH 1 0.0000
399 ABDOMINAL DISCOMFORT 2 0.0000
400 SKIN EXFOLIATION 1 0.0000
401 BALANCE DISORDER 1 0.0000
402 PRODUCT STORAGE ERROR 1 0.0000
403 INSOMNIA 3 0.0000
404 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
405 NO ADVERSE EVENT 2 0.0000
406 ADVERSE EVENT 1 0.0000
407 CARDIAC DISORDER 1 0.0000
408 DYSPNOEA 6 0.0000
409 PULMONARY EMBOLISM 1 0.0000
410 SYNCOPE 1 0.0000
411 FLUSHING 1 0.0000
412 CHEST DISCOMFORT 1 0.0000
413 HAEMOGLOBIN DECREASED 1 0.0000
414 ABDOMINAL PAIN 2 0.0000
415 CHILLS 1 0.0000
416 VOMITING 4 0.0000
417 JOINT SWELLING 1 0.0000
418 EMOTIONAL DISTRESS 1 0.0000
419 OEDEMA PERIPHERAL 1 0.0000
420 VISUAL IMPAIRMENT 1 0.0000
421 LOSS OF CONSCIOUSNESS 1 0.0000
422 DRUG INEFFECTIVE 10 0.0000
423 NEUTROPENIA 1 0.0000
424 PERIPHERAL SWELLING 1 0.0000
425 DIZZINESS 3 0.0000
426 MYALGIA 1 0.0000
427 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
428 PRODUCT USE ISSUE 1 0.0000
429 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
430 ABDOMINAL PAIN UPPER 1 0.0000
431 OVERDOSE 1 0.0000
432 ANXIETY 1 0.0000